SEC Form 4 · accession 0001513162-17-000184
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Kumar
Director
Period of report
Jun 5, 2017
Accepted (ET)
Jun 6, 2017 · 11:11 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2017 | P | 10,000 | $0.90 | A | 124,408 | D |
Table II — derivative securities
No Table II lines on this filing.